WFA
WST icon

Wellspring Financial Advisors’s West Pharmaceutical WST Stock Holding History

Wellspring Financial Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-332
Closed -$136K – 142
2022
Q1 		$136K Buy
+332
New +$130K 0.04% 115

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Wellspring Financial Advisors's WST Position: Q2 2022 in Review

Wellspring Financial Advisors sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 332 shares — an estimated $136K sold.

Wellspring Financial Advisors first reported a position in WST in Q1 2022 and held it in 1 quarter. The position peaked at $136K in Q1 2022. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

  • Wellspring Financial Advisors reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • Wellspring Financial Advisors sold 332 West Pharmaceutical shares in Q2 2022, an estimated $136K.
  • Wellspring Financial Advisors first reported a position in West Pharmaceutical in Q1 2022 and held it in 1 quarter.
  • Wellspring Financial Advisors's West Pharmaceutical position peaked at $136K in Q1 2022.
  • 655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on Wellspring Financial Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.